The company invested $718 million in cash for acquisitions in the first half of 2026, with Nalu Medical, Inc. being a primary target.
Filing excerpt
During the first six months of 2026, cash provided by (used for) investing activities included net cash payments of $718 million for acquisitions of multiple businesses, primarily related to Nalu Medical, Inc.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Vendors
Vendors named
sec-10qacquisitionCompletedGet every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e8118e8f-a127-4142-b692-a28d4bbf0c8c returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "e8118e8f-a127-4142-b692-a28d4bbf0c8c",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-08-04T07:04:22.117+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The company invested $718 million in cash for acquisitions in the first half of 2026, with Nalu Medical, Inc. being a primary target. This continued M&A activity creates immediate needs for integrating operations, supply chains, and IT systems, presenting opportunities for relevant vendors.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "Net cash payments for acquisitions of multiple businesses during the first six months of 2026.",
"dollar_millions": 718
},
"summary": "BSX spent $718M on acquisitions in H1 2026, primarily for Nalu Medical, Inc.",
"excerpts": "During the first six months of 2026, cash provided by (used for) investing activities included net cash payments of $718 million for acquisitions of multiple businesses, primarily related to Nalu Medical, Inc.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000053/bsx-20260630.htm",
"filing_date": "2026-08-03",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Active integration needs",
"signal_category": "strategic",
"vendors_mentioned": [
"Nalu Medical, Inc.",
"MiRus LLC",
"Bolt Medical, Inc.",
"SoniVie Ltd.",
"Cortex, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/e8118e8f-a127-4142-b692-a28d4bbf0c8c \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.